Company / Financials
Nuo Therapeutics, Inc. Financials
FY2011-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$721.0K
FY2017 · +52.6% YoY
Net Income
-$15.0M
FY2017 · -163.0% YoY
Profit Margin
-2077.4%
FY2017 · net income / revenue
ROE
-3102.0%
FY2017 · return on equity
Total Assets
$1.4M
FY2017
Total Debt
-
FY2017
Equity
$482.9K
FY2017
ROA
-1051.8%
FY2017 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score -45.34 (distress zone, below 1.23 threshold)
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$721.0K+52.6% YoYNet Income HistoryProfit after all expenses and taxes-$15.0M-163.0% YoYGross Profit HistoryRevenue minus cost of goods sold-$370.0K-44.2% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$1.1M+49.7% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$15.5M-184.6% YoYSG&A Expense HistorySelling, general, and administrative expenses$3.8M+16.1% YoYR&D Expense HistoryResearch and development spending$1.3M+30.8% YoYInterest Expense HistoryCost of borrowing and debt obligations$10.8KIncome Tax HistoryTotal income tax expense-EPS (Basic) HistoryBasic earnings per share-$0.580.0% YoY